Publicou 4 edições por ano
ISSN Imprimir: 0731-8898
ISSN On-line: 2162-6537
Indexed in
Induction of Apoptosis as a Potential Chemopreventive Effect of Dual Cycloxygenase Inhibitor, Diclofenac, in Early Colon Carcinogenesis
RESUMO
We evaluated the role of diclofenac, a dual cycloxygenase inhibitor, in chemoprevention of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in rat model. In a six-week long treatment with DMH (initiation stage), colonic mucosa showed a rich presence of preneoplastic lesions, such as multiple plaque lesions (MPL), aberrant crypt foci (ACF), and histologically well-characterized dysplasia. Control animals were free from these features while simultaneous treatment of DMH and diclofenac resulted in a significant reduction of these. The Diclofenac-only group did not show any prominent carcinogenic feature. The colonic tissue showed increased COX-2 expression in the DMH group, immunohistochemically and by western blotting. Apoptosis was quantified in isolated colonocytes by fluorescent staining and by TUNEL assay in tissue sections. The number of apoptotic cells was few in the DMH group, while it was featured prominently in all the other groups. The dose of the diclofenac used in the present study was established at an anti-inflammatory dose by the carrageenan-induced rodent paw oedema test. Because ACF can be accepted as reliable prognostic biomarkers in colon carcinogenesis, its inhibition and also the induction of the apoptosis process may favorably indicate the preclinical promise for chemoprevention of colon cancer as demonstrated in the initiation phase of carcinogenesis.
-
Kaur Jasmeet, Vaish Vivek, Sanyal Sankar Nath, COX-2 as a molecular target of colon cancer chemoprevention: Promise and reality, Biomedicine & Aging Pathology, 2, 3, 2012. Crossref
-
Vieira Amélia C.F., Serra Arménio C., Carvalho Rui A., Gonsalves Alexandra, Figueiras Ana, Veiga Francisco J., Basit Abdul W., Rocha Gonsalves António M. d’A., Microwave synthesis and in vitro stability of diclofenac-β-cyclodextrin conjugate for colon delivery, Carbohydrate Polymers, 93, 2, 2013. Crossref
-
Kaur Jasmeet, Sanyal Sankar Nath, PI3-kinase/Wnt association mediates COX-2/PGE2 pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac, Tumor Biology, 31, 6, 2010. Crossref
-
Kaur Jasmeet, Sanyal Sankar Nath, Modulation of inflammatory changes in early stages of colon cancer through activation of PPARγ by diclofenac, European Journal of Cancer Prevention, 19, 5, 2010. Crossref
-
Kaur Jasmeet, Sanyal S.N., Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1α and VEGF, Molecular Carcinogenesis, 50, 9, 2011. Crossref
-
Vieira Amélia C.F., Serra Arménio C., Veiga Francisco J., Gonsalves António M.d’A Rocha, Basit Abdul W., Murdan Sudaxshina, Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats, International Journal of Pharmaceutics, 500, 1-2, 2016. Crossref
-
Zerbini Luiz F., Tamura Rodrigo E., Correa Ricardo G., Czibere Akos, Cordeiro Jason, Bhasin Manoj, Simabuco Fernando M., Wang Yihong, Gu Xuesong, Li Linglin, Sarkar Devanand, Zhou Jin-Rong, Fisher Paul B., Libermann Towia A., Lebedeva Irina V., Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy, PLoS ONE, 6, 9, 2011. Crossref
-
Gottfried Eva, Lang Sven A., Renner Kathrin, Bosserhoff Anja, Gronwald Wolfram, Rehli Michael, Einhell Sabine, Gedig Isabel, Singer Katrin, Seilbeck Anton, Mackensen Andreas, Grauer Oliver, Hau Peter, Dettmer Katja, Andreesen Reinhard, Oefner Peter J., Kreutz Marina, Rafael Moreno-Sanchez, New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells, PLoS ONE, 8, 7, 2013. Crossref
-
Akbari Nasrin, Ghorbani Mohammad, Salimi Vahid, Alimohammadi Alimohammad, Khamseh Mohammad E., Akbari Hamideh, Nourbakhsh Mitra, Sheikhi Alireza, Taghavi S. Fahimeh, Tavakoli-Yaraki Masoumeh, Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas, BMC Endocrine Disorders, 20, 1, 2020. Crossref
-
Kaur Jasmeet, Sanyal S. N., Alterations in membrane fluidity and dynamics in experimental colon cancer and its chemoprevention by diclofenac, Molecular and Cellular Biochemistry, 341, 1-2, 2010. Crossref